Icon Plc (ICLR) Expected to Earn FY2017 Earnings of $5.37 Per Share
Icon Plc (NASDAQ:ICLR) – Equities research analysts at First Analysis issued their FY2017 earnings per share estimates for shares of Icon in a note issued to investors on Monday. First Analysis analyst T. Van. Fleet expects that the medical research company will post earnings of $5.37 per share for the year. First Analysis also issued estimates for Icon’s Q4 2017 earnings at $1.41 EPS, Q1 2018 earnings at $1.36 EPS, Q2 2018 earnings at $1.49 EPS and FY2018 earnings at $5.95 EPS.
Icon (NASDAQ:ICLR) last announced its quarterly earnings data on Thursday, October 26th. The medical research company reported $1.35 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.32 by $0.03. Icon had a return on equity of 28.42% and a net margin of 16.37%. The company had revenue of $440.30 million for the quarter, compared to analyst estimates of $438.09 million. During the same quarter in the previous year, the company earned $1.19 EPS. The firm’s revenue for the quarter was up 4.8% compared to the same quarter last year.
Shares of Icon (NASDAQ ICLR) opened at $112.72 on Wednesday. Icon has a twelve month low of $73.76 and a twelve month high of $124.48. The firm has a market capitalization of $6,020.62, a P/E ratio of 21.34, a price-to-earnings-growth ratio of 1.72 and a beta of 0.56. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.90 and a quick ratio of 1.90.
A number of institutional investors and hedge funds have recently modified their holdings of the business. WCM Investment Management CA increased its holdings in shares of Icon by 2.1% during the 3rd quarter. WCM Investment Management CA now owns 4,047,221 shares of the medical research company’s stock worth $460,897,000 after buying an additional 82,115 shares during the last quarter. FMR LLC increased its holdings in Icon by 38.4% in the 2nd quarter. FMR LLC now owns 2,291,005 shares of the medical research company’s stock valued at $224,037,000 after purchasing an additional 635,950 shares in the last quarter. Wasatch Advisors Inc. increased its holdings in Icon by 0.7% in the 2nd quarter. Wasatch Advisors Inc. now owns 1,850,244 shares of the medical research company’s stock valued at $180,935,000 after purchasing an additional 13,104 shares in the last quarter. Renaissance Technologies LLC increased its holdings in Icon by 20.6% in the 2nd quarter. Renaissance Technologies LLC now owns 1,153,160 shares of the medical research company’s stock valued at $112,768,000 after purchasing an additional 197,300 shares in the last quarter. Finally, Janus Henderson Group PLC increased its holdings in Icon by 48.4% in the 2nd quarter. Janus Henderson Group PLC now owns 1,068,159 shares of the medical research company’s stock valued at $104,488,000 after purchasing an additional 348,292 shares in the last quarter. Institutional investors own 89.95% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “Icon Plc (ICLR) Expected to Earn FY2017 Earnings of $5.37 Per Share” was first published by American Banking News and is the property of of American Banking News. If you are accessing this story on another website, it was illegally copied and reposted in violation of United States and international copyright law. The original version of this story can be viewed at https://www.americanbankingnews.com/2017/12/13/icon-plc-iclr-expected-to-earn-fy2017-earnings-of-5-37-per-share.html.
ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies.
Receive News & Ratings for Icon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Icon and related companies with MarketBeat.com's FREE daily email newsletter.